These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29670109)

  • 1. Mutation hotspots at CTCF binding sites coupled to chromosomal instability in gastrointestinal cancers.
    Guo YA; Chang MM; Huang W; Ooi WF; Xing M; Tan P; Skanderup AJ
    Nat Commun; 2018 Apr; 9(1):1520. PubMed ID: 29670109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-cancer analysis of somatic mutations and epigenetic alterations in insulated neighbourhood boundaries.
    Pinoli P; Stamoulakatou E; Nguyen AP; Rodríguez Martínez M; Ceri S
    PLoS One; 2020; 15(1):e0227180. PubMed ID: 31945090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatin loop anchors are associated with genome instability in cancer and recombination hotspots in the germline.
    Kaiser VB; Semple CA
    Genome Biol; 2018 Jul; 19(1):101. PubMed ID: 30060743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of coding and non-coding mutational hotspots in cancer genomes.
    Piraino SW; Furney SJ
    BMC Genomics; 2017 Jan; 18(1):17. PubMed ID: 28056774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTCF/cohesin-binding sites are frequently mutated in cancer.
    Katainen R; Dave K; Pitkänen E; Palin K; Kivioja T; Välimäki N; Gylfe AE; Ristolainen H; Hänninen UA; Cajuso T; Kondelin J; Tanskanen T; Mecklin JP; Järvinen H; Renkonen-Sinisalo L; Lepistö A; Kaasinen E; Kilpivaara O; Tuupanen S; Enge M; Taipale J; Aaltonen LA
    Nat Genet; 2015 Jul; 47(7):818-21. PubMed ID: 26053496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and genetic determinants of mutation rate variability in regulatory elements of cancer genomes.
    Lee CA; Abd-Rabbo D; Reimand J
    Genome Biol; 2021 May; 22(1):133. PubMed ID: 33941236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatin accessibility contributes to simultaneous mutations of cancer genes.
    Shi Y; Su XB; He KY; Wu BH; Zhang BY; Han ZG
    Sci Rep; 2016 Oct; 6():35270. PubMed ID: 27762310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of directional CTCF recognition of a diverse range of genomic sites.
    Yin M; Wang J; Wang M; Li X; Zhang M; Wu Q; Wang Y
    Cell Res; 2017 Nov; 27(11):1365-1377. PubMed ID: 29076501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Mutations Form at CTCF-Cohesin Binding Sites in Melanoma Due to Uneven Nucleotide Excision Repair across the Motif.
    Poulos RC; Thoms JAI; Guan YF; Unnikrishnan A; Pimanda JE; Wong JWH
    Cell Rep; 2016 Dec; 17(11):2865-2872. PubMed ID: 27974201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal aberrations in primary PDGFRA-mutated gastrointestinal stromal tumors.
    Schaefer IM; Delfs C; Cameron S; Gunawan B; Agaimy A; Ghadimi BM; Haller F
    Hum Pathol; 2014 Jan; 45(1):85-97. PubMed ID: 24157063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The landscape and driver potential of site-specific hotspots across cancer genomes.
    Juul RI; Nielsen MM; Juul M; Feuerbach L; Pedersen JS
    NPJ Genom Med; 2021 May; 6(1):33. PubMed ID: 33986299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insertions and Deletions Target Lineage-Defining Genes in Human Cancers.
    Imielinski M; Guo G; Meyerson M
    Cell; 2017 Jan; 168(3):460-472.e14. PubMed ID: 28089356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types.
    Chen T; Wang Z; Zhou W; Chong Z; Meric-Bernstam F; Mills GB; Chen K
    BMC Genomics; 2016 Jun; 17 Suppl 2(Suppl 2):394. PubMed ID: 27356755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis.
    Letouzé E; Shinde J; Renault V; Couchy G; Blanc JF; Tubacher E; Bayard Q; Bacq D; Meyer V; Semhoun J; Bioulac-Sage P; Prévôt S; Azoulay D; Paradis V; Imbeaud S; Deleuze JF; Zucman-Rossi J
    Nat Commun; 2017 Nov; 8(1):1315. PubMed ID: 29101368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential DNA repair underlies mutation hotspots at active promoters in cancer genomes.
    Perera D; Poulos RC; Shah A; Beck D; Pimanda JE; Wong JW
    Nature; 2016 Apr; 532(7598):259-63. PubMed ID: 27075100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic landscape and mutational impacts of recurrently mutated genes in cancers.
    Liu B; Hu FF; Zhang Q; Hu H; Ye Z; Tang Q; Guo AY
    Mol Genet Genomic Med; 2018 Nov; 6(6):910-923. PubMed ID: 30107644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Significant Regulatory Mutation Burden at a High-Affinity Position of the CTCF Motif in Gastrointestinal Cancers.
    Umer HM; Cavalli M; Dabrowski MJ; Diamanti K; Kruczyk M; Pan G; Komorowski J; Wadelius C
    Hum Mutat; 2016 Sep; 37(9):904-13. PubMed ID: 27174533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A system for detecting high impact-low frequency mutations in primary tumors and metastases.
    Anjanappa M; Hao Y; Simpson ER; Bhat-Nakshatri P; Nelson JB; Tersey SA; Mirmira RG; Cohen-Gadol AA; Saadatzadeh MR; Li L; Fang F; Nephew KP; Miller KD; Liu Y; Nakshatri H
    Oncogene; 2018 Jan; 37(2):185-196. PubMed ID: 28892047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
    Glinsky GV
    Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational Biases Drive Elevated Rates of Substitution at Regulatory Sites across Cancer Types.
    Kaiser VB; Taylor MS; Semple CA
    PLoS Genet; 2016 Aug; 12(8):e1006207. PubMed ID: 27490693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.